Last kr267.10 DKK
Change Today -2.40 / -0.89%
Volume 2.5M
NOVOB On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
New York
Frankfurt
Frankfurt
As of 11:01 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ingelise Saunders Mph,BSc

Vice President of International Operations, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 41 board members in 7 different organizations across 13 different industries.

See Board Relationships
65--

Background*

Mrs. Ingelise Saunders, Mph, B.Sc. serves as the Chief Executive Officer of SLS Invest. Mrs. Saunders has been Chief Executive Officer of TD Vaccines A/S since November 2009 and serves as its President. She served as Chief Executive Officer of Action Pharma A/S since March 2010. She served as the Chief Executive Officer at Celltech Pharmaceuticals at Celltech Group Limited since March 2002. She served as Chief Executive Officer of UCB Pharma Limited. She served as Global ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Director
Chief Executive Officer and Director
Chief Executive Officer, President and Director
Member of the Board
2003-2004
Former Chief Executive Officer of Celltech Pharmaceuticals
2004-Present
Independent Director, Member of Commercialisation & Business Development Committee for The Eu Territory and Member of Remuneration & Nomination Committee
2005-N/A
Former Director
2009-N/A
Former Director and Member of Nomination & Compensation Committee

Education*

Master's Degree
Københavns Universitet

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr267.10 DKK -2.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Rakesh Kapoor Chief Executive Officer, Executive Director and Member of Nomination Committee
Reckitt Benckiser Group plc
4.4M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.